|
|
Actualités & Evénements
Actualités
|
18-nov.-2009
This new book reviews the use of pharmacogenetics across all stages of the health innovation cycle from research through to uptake by doctors and patients. It focuses on how to optimise use of pharmacogenetics to deliver effective innovations for public health, and design policies that enhance their economic and social benefits.
|
|
20-mars-2009
This document focuses on efforts in the United States to develop metrics to support sound decision choices by industry and consumers in the selection and use of biobased products. Public policy initiatives have been important in spurring the movement toward increased use of biobased products in the effort to lighten the US environmental footprint and enhance its energy security. This has included developing metrics based on sound science that also provide useful information to inform consumer selections of biobased products.
|
|
24-oct.-2008
The links between innovation, productivity, health and wealth are recognised by many countries and the need to encourage innovation is also apparent. Investing in and encouraging innovation is a priority for many jurisdictions as is the affordability, quality and sustainability of healthcare systems.
|
|
22-oct.-2008
The Biotechnology Division of the OECD organized an experts workshop on “Knowledge Markets in the Life Sciences” in Washington, DC on October 16-17, 2008. Its purpose was to explore whether Knowledge Markets could be more broadly used and to identify what governments may need to do to help make such new markets become a reality. This workshop is the first policy meeting to consider what new exchange mechanisms improve access to and use of the vast amounts of data, knowledge and information created in the biomedical sciences.
|
|
22-oct.-2008
At a workshop organized by the OECD Biotechnology Division in October in the United Kingdom, experts discussed how to improve the development and use of biomarkers in health care. Topics included: data and knowledge sharing for biomarker research; the creation of an evidence base and the clinical evaluation of biomarkers; the regulatory and policy framework for safe and efficient development of biomarkers; and business models for biomarker discovery, development and commercialization.
|
Evénements
|
du 23-juil.-2009 au 24-juil.-2009
Some of the topics dicussed at this workshop held on Montreal, Canada were: existing sector, national, or international approaches for assessment of sustainability of bio-based products, such as bio-based chemicals, bio-based plastics, enzymes, bio-based materials, and biofuels.
|
|
du 09-juil.-2009 au 10-juil.-2009
Synthetic biology is a transformative set of technologies which offer great opportunities for the construction of bioengineered parts, devices and microorganisms. However, achieving the rewards offered by synthetic biology will require addressing a range of social, economic, ethical, and legal issues as well as overcoming scientific and technical challenges. Given the enormous promise of synthetic biology, it is critical to develop a framework and to engage the public in an informed dialogue.
|
|
du 06-oct.-2008 au 07-oct.-2008
An expert workshop will be held in Cambridge, United Kingdom, to discuss a number of analytical papers that address some key policy issues in the development and uptake of biomarkers. A policy report based on the papers and the workshop discussion is planned for delivery before the end of 2008.
|
|
du 20-juin-2007 au 21-juin-2007
Les maladies infectieuses et négligées font souffrir les familles, la société et l’économie, en particulier dans les pays en voie de développement. Selon l’Organisation mondiale de la santé, un milliard d’êtres humains souffriraient de ces maladies, contre lesquelles il existe peu de nouveaux outils thérapeutiques ou traitements. Le Forum de haut niveau de l’OCDE sur les maladies infectieuses négligées et émergentes examinera les moyens à mettre en œuvre pour améliorer la situation.
|
Haut de la page
|
|
